EcoR1 Capital, LLC's Form 4 filing
Odonate Therapeutics, Inc. (ODT) · filed Dec 10, 2021
- Accession no.
- 0001567619-21-021902
- Filed
- Dec 10, 2021
- Trade date
- Dec 1-10, 2021
- Filing delay
- 9 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market purchases total $308.7K. Open-market sales total $9.74M. It was filed 9 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| EcoR1 Capital, LLCCIK 0001587114 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2021 | Common Stock | PPurchaseAcquired | +185,941 | $1.66 | +$308,662.06 | 5,701,669 | Indirect | |
| Dec 1, 2021 | Common Stock | SSaleDisposed | −185,941 | $1.66 | −$308,662.06 | 5,701,669 | Indirect | |
| Dec 9, 2021 | Common Stock | SSaleDisposed | −156,669 | $1.82 | −$285,137.58 | 5,545,000 | Indirect | |
| Dec 10, 2021 | Common Stock | SSaleDisposed | −5,000,000 | $1.66 | −$8,300,000 | 545,000 | Indirect | |
| Dec 10, 2021 | Common Stock | SSaleDisposed | −545,000 | $1.55 | −$844,750 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.